Active Ingredients: Ciprofloxacin
Search Menu Abstract Background.
Concerns have recently emerged about the efficacy and the quality of antibacterial generic products approved for use in humans.
Therefore; this study was aimed to determine the prevalence of toxoplasmosis infection and its possible risk factors associated with pregnant women attending antenatal clinics in Hawassa and Yiregalem Hospitals, Southern Ethiopia.
The study was done in antenatal care clinics of Hawassa and Yiregalem Hospitals in Southern, Ethiopia.
Five hundred pregnant women were interviewed with a pretested structured questionnaire to collect risk factors and socio-demographic data.
Data were analyzed using SPSS version 20 statistical software. The risk factors were tested for significance using Bivariate and multivariate analysis.
To determine outcome, smear was performed at month 5 or 6.
As a consequence, treatment fails and this potentially enhances the selection of bacterial resistance Rodriguez et al. Weir et al. In addition, a number of formulations had the concentration of ciprofloxacin sufficiently lower to have negative impact on clinical outcome leading to increased risk of bacterial resistance.
Prazuck et al. One collected formulation in fact expired 11 months ago. This study highlighted the availability of poor quality of ciprofloxacin formulations in India.
Previous studies have also shown that the production of substandard drugs is common in Southeast Asia Newton et al. Bate et al. They collected 50 and 53 ciprofloxacin treatment packs from Delhi and Chennai pharmacies respectively.
The quality was determined based on the content of ciprofloxacin and disintegration test.